Influenza MP (62-70) – 1 mg

Overview

Influenza MP (62-70) is a vital peptide that plays a significant role in understanding the immune response to the influenza virus. This peptide is derived from the matrix protein of the influenza virus, specifically focusing on the amino acid residues 62 to 70. It encompasses the core sequence for a new major histocompatibility complex class II-restricted T-cell epitope, which has been identified in the peripheral blood of patients afflicted with influenza A. By studying this peptide, researchers can gain insights into the immune mechanisms involved during influenza infections, contributing to the development of more effective vaccines and therapies.

Key Features

• Fragment of influenza virus matrix protein
• Includes MHC II-restricted T-cell epitope
• Identified in the peripheral blood of influenza A patients
• Essential for research in vaccine development
• 1 mg quantity, suitable for various applications

Specifications

FAQ

What is the significance of the Influenza MP (62-70) peptide?

This peptide is crucial for researching the immune response to influenza virus infections. Its identification as a T-cell epitope allows scientists to explore immune interactions and refine vaccine strategies.

How can I utilize the Influenza MP (62-70) in my research?

Researchers can use this peptide in immunological assays to study T-cell responses, enhancing the understanding of the immune mechanisms underlying influenza.

Where can I find more peptides for my studies?

For additional options, check out our extensive collection of peptides that cater to various research needs, including our high-quality PKG Substrate RKRSRAE.

If you’re interested in exploring related products, consider our Autocamtide-2 KKALRRQETVDAL or the CREBtide labeled with 5-FAM KRREILSRRPSYR.